Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma

Primary effusion lymphoma (PEL) is an aggressive B-cell malignancy without effective treatment, and caused by the infection of Kaposi’s sarcoma-associated herpesvirus (KSHV), predominantly in its latent form. Previously we showed that the SUMO2-interacting motif within the viral latency-associated n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ling, Zhu, Qing, Zhou, Feng, Tan, Hongsheng, Xu, Wenjia, Pan, Chengling, Zhu, Caixia, Wang, Yuyan, Zhang, Hong, Fu, Wenwei, Qian, Zhikang, Yuan, Zhenghong, Xu, Hongxi, Wei, Fang, Cai, Qiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932820/
https://www.ncbi.nlm.nih.gov/pubmed/31830143
http://dx.doi.org/10.1371/journal.ppat.1008174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932820/
https://www.ncbi.nlm.nih.gov/pubmed/31830143
http://dx.doi.org/10.1371/journal.ppat.1008174

Ejemplares similares